Clinical Trials Logo

Clinical Trial Summary

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms


Clinical Trial Description

80 female patients evaluated for sexual function after receiving Mirabegron 50 mg once daily for 6 months for treatment of overactive bladder symptoms ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04511273
Study type Observational
Source Kasr El Aini Hospital
Contact Samer Morsy
Phone 01000908851
Email Samermorsy1@gmail.com
Status Not yet recruiting
Phase
Start date September 1, 2020
Completion date April 1, 2021